These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 7757990

  • 1. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
    Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ.
    Cancer Res; 1995 Jun 01; 55(11):2380-6. PubMed ID: 7757990
    [Abstract] [Full Text] [Related]

  • 2. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
    Taipale J, Matikainen S, Hurme M, Keski-Oja J.
    Cell Growth Differ; 1994 Dec 01; 5(12):1309-19. PubMed ID: 7696179
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes.
    Batova A, Danielpour D, Pirisi L, Creek KE.
    Cell Growth Differ; 1992 Nov 01; 3(11):763-72. PubMed ID: 1334692
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG.
    Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts.
    Zhou H, Hammonds RG, Findlay DM, Martin TJ, Ng KW.
    J Cell Physiol; 1993 Apr 01; 155(1):112-9. PubMed ID: 8385674
    [Abstract] [Full Text] [Related]

  • 8. Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell.
    Baselga J, Maerz WJ, Moy D, Miller WH, Castro L, Reuter VE, Yao TJ, Masui H, Dmitrovsky E.
    Oncogene; 1993 Dec 01; 8(12):3257-63. PubMed ID: 8247529
    [Abstract] [Full Text] [Related]

  • 9. All-trans-retinoic acid inhibits the proliferation of cell lines derived from human cervical neoplasia.
    Behbakht K, DeGeest K, Turyk ME, Wilbanks GD.
    Gynecol Oncol; 1996 Apr 01; 61(1):31-9. PubMed ID: 8626114
    [Abstract] [Full Text] [Related]

  • 10. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M, Miyazaki H, Kojima S.
    J Cell Physiol; 1998 Sep 01; 176(3):565-73. PubMed ID: 9699509
    [Abstract] [Full Text] [Related]

  • 11. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells.
    Danielpour D.
    J Cell Physiol; 1996 Jan 01; 166(1):231-9. PubMed ID: 8557772
    [Abstract] [Full Text] [Related]

  • 12. Retinoic acid induces secretion of transforming growth factors by PC12 pheochromocytoma cells.
    Cosgaya JM, Perona R, Aranda A.
    Oncogene; 1997 Feb 06; 14(5):579-87. PubMed ID: 9053856
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
    Borger DR, Mi Y, Geslani G, Zyzak LL, Batova A, Engin TS, Pirisi L, Creek KE.
    Virology; 2000 May 10; 270(2):397-407. PubMed ID: 10792999
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines.
    Rogers SL, Cutts JL, Gegick PJ, McGuire PG, Rosenberger C, Krisinski S.
    Exp Cell Res; 1994 Apr 10; 211(2):252-62. PubMed ID: 8143771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.